Articles published by Kala Pharmaceuticals, Inc.
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
December 27, 2022
Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
Kala Pharmaceuticals Announces Appointment of Marjan Farid, M.D., to its Board of Directors
November 01, 2022
Kala Pharmaceuticals Announces Reverse Stock Split
October 20, 2022
Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call
April 28, 2021
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following